Ismail, J.; Shebaby, W.; Azar Atallah, S.; Taleb, R.I.; Kawrani, S.; Faour, W.; Mroueh, M.
Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells. Biomedicines 2025, 13, 520.
https://doi.org/10.3390/biomedicines13020520
AMA Style
Ismail J, Shebaby W, Azar Atallah S, Taleb RI, Kawrani S, Faour W, Mroueh M.
Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells. Biomedicines. 2025; 13(2):520.
https://doi.org/10.3390/biomedicines13020520
Chicago/Turabian Style
Ismail, Jana, Wassim Shebaby, Shirine Azar Atallah, Robin I. Taleb, Sara Kawrani, Wissam Faour, and Mohamad Mroueh.
2025. "Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells" Biomedicines 13, no. 2: 520.
https://doi.org/10.3390/biomedicines13020520
APA Style
Ismail, J., Shebaby, W., Azar Atallah, S., Taleb, R. I., Kawrani, S., Faour, W., & Mroueh, M.
(2025). Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells. Biomedicines, 13(2), 520.
https://doi.org/10.3390/biomedicines13020520
